 One of the leading causes of disability in the United States is peripheral neuropathy (PN). Although closely associated with diabetes, other conditions may also contribute to PN, including cardiometabolic risk factors. Until recently, many believed persistent hyperglycemia preceded the development of PN. However, new studies reveal a higher prevalence of PN in individuals struggling with prediabetes.
In other words, supposed idiopathic neuropathy may be a marker for prediabetes. This makes a double-pronged approach to fighting the condition even more critical, one that addresses both vascular and metabolic factors by pairing NeuropaCalm and the next generation nerve supplement, NeuraVite.Microvascular Circulation and Laser Light Therapy Laser light therapy (LLT) has emerged as an important treatment option for addressing the symptoms of peripheral neuropathy in recent years. Many chiropractors and neuropathy specialists utilize LLT to enhance and encourage microvascular circulation. But if you’re not using NeuropaCalm, it’s time to reconsider your options. NeuropaCalm’s innovative, hard-case infrared device can improve outcomes in less time. How is this possible? It offers a radiologically superior output, generating up to five times more power than competitor devices.
0 Comments
 Patients suffering from diabetes and peripheral neuropathy visit your medical facility every day. Many of these individuals feel so overwhelmed managing diabetes and blood sugar levels that they neglect other vital areas of their health. This proves especially true when it comes to secondary conditions like peripheral neuropathy.
As a result, they may fail to grasp the essential role of nitric oxide in supporting circulatory health. Nevertheless, this essential molecule contributes to better sensory perception and vasodilation. It's a key component of an effective neuropathy therapy. Keep reading to find out more about nitric oxide’s vital role in neurological and circulatory health and then pass this important information on to your patients. |
ARTICLES
August 2024
|
RSS Feed
|
|
NeuropaCalm® name and logo are registered trademarks. © 2024 NeuropaCalm
ALL RIGHT RESERVED
PRIVACY POLICY
REPAIRS
ALL RIGHT RESERVED
PRIVACY POLICY
REPAIRS
Site powered by Good Ink